Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Favourable Response More Likely with Neoadjuvant Dual Immune Checkpoint Inhibitor Than...

Ogkologos - 11 Απριλίου, 2024

Neoadjuvant Chemoimmunotherapy Superior to Neoadjuvant Chemotherapy with Event-Free Survival Benefit in...

Ogkologos - 10 Απριλίου, 2024

FDA Approves Mirvetuximab Soravtansine-gynx for FRα-positive, Platinum-resistant Epithelial Ovarian, Fallopian Tube,...

Ogkologos - 9 Απριλίου, 2024

Omission of Completion Axillary Lymph Node Dissection Noninferior to More Extensive...

Ogkologos - 8 Απριλίου, 2024

A PET-based, pCR-adapted Chemotherapy De-escalation Strategy Associated with an Excellent 3-year...

Ogkologos - 5 Απριλίου, 2024

Oxaliplatin-Based Adjuvant Chemotherapy Shows Good Tolerance and Similar Time To Recurrence...

Ogkologos - 4 Απριλίου, 2024

Drug Combination May Have Potential for Cancers with TP53 Mutations

Ogkologos - 4 Απριλίου, 2024

EMA Recommends Extension of Therapeutic Indications for Irinotecan Hydrochloride Trihydrate

Ogkologos - 3 Απριλίου, 2024

Stress-Induced Immune Changes May Help Cancer Spread

Ogkologos - 2 Απριλίου, 2024

Efficacy of Afamitresgene Autoleucel for HLA-A*02-positive and MAGE-A4-positive Synovial Sarcoma Following...

Ogkologos - 2 Απριλίου, 2024

1...868788...440 Σελίδα 87 από 440

MOST POPULAR

How to Stay Healthy After Cancer

28 Οκτωβρίου, 2020

EMA Recommends Extension of Therapeutic Indications for Trifluridine/Tipiracil

7 Ιουλίου, 2023

Listening to Patient Narratives

9 Ιουνίου, 2020

Experts Urge to Remove Care Inequalities for Adolescents and Young Adults...

8 Απριλίου, 2021

Φόρτωση περισσοτέρων

Favourable Response More Likely with Neoadjuvant Dual Immune Checkpoint Inhibitor Than...

Neoadjuvant Chemoimmunotherapy Superior to Neoadjuvant Chemotherapy with Event-Free Survival Benefit in...

FDA Approves Mirvetuximab Soravtansine-gynx for FRα-positive, Platinum-resistant Epithelial Ovarian, Fallopian Tube,...

Omission of Completion Axillary Lymph Node Dissection Noninferior to More Extensive...

A PET-based, pCR-adapted Chemotherapy De-escalation Strategy Associated with an Excellent 3-year...

Oxaliplatin-Based Adjuvant Chemotherapy Shows Good Tolerance and Similar Time To Recurrence...

Drug Combination May Have Potential for Cancers with TP53 Mutations

EMA Recommends Extension of Therapeutic Indications for Irinotecan Hydrochloride Trihydrate

Stress-Induced Immune Changes May Help Cancer Spread

Efficacy of Afamitresgene Autoleucel for HLA-A*02-positive and MAGE-A4-positive Synovial Sarcoma Following...

MOST POPULAR

How to Stay Healthy After Cancer

EMA Recommends Extension of Therapeutic Indications for Trifluridine/Tipiracil

Listening to Patient Narratives

Experts Urge to Remove Care Inequalities for Adolescents and Young Adults...

HOT NEWS

FDA Approves Cosibelimab-ipdl for Metastatic or Locally Advanced Cutaneous Squamous Cell...

Talquetamab Continuous To Demonstrate High Overall Response Rates in Heavily Pretreated...

Female Breast Cancer is Now the Most Commonly Diagnosed Cancer in...

Breast Cancer Patient Takes Silly Pictures During Each Radiation Treatment to...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ